Brookfield renews talks to acquire Spanish blood-plasma company Grifols for €7 billion, but uncertainty remains over a formal offer.
Six teams reportedly pursue Kevin Durant as the Suns consider retooling amid the star's hefty contract and the potential return of significant draft assets.
Brookfield renews talks to acquire Spanish blood-plasma company Grifols for €7 billion, but uncertainty remains over a formal offer.
Six teams reportedly pursue Kevin Durant as the Suns consider retooling amid the star's hefty contract and the potential return of significant draft assets.